Pharmaceuticals

Slide2-min_(1)71.JPG

Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Technology (Column-Based Method, Microarray-Based Method), By Product, By End-User (Pharmaceutical Companies, Academic Research Institute, Diagnostic Laboratories), By Region, And By Segment Forecasts, 2025-2034

Global Nucleic Acid Therapeutics CDMO Market Size is valued at USD 2,540.9 Million in 2024 and is predicted to reach USD 8,688.2 Million by the year 2034 at an 13.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings...

View Sample PDF

Slide2-min_(1)46.JPG

RNA-based Therapeutics Market Size, Share & Trends Analysis Report By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, RNA Aptamer, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Oncology, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Others), By End User (Hospitals and Clinics, Research Settings), By Region, And By Segment Forecasts, 2025-2034

Global RNA-based Therapeutics Market is valued at USD 12.4 Billion in 2024 and is predicted to reach USD 22.6 Billion by the year 2034 at a 6.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: ...

View Sample PDF

slid74.JPG

Peptide CDMO (Pharmaceutical) Market Size, Share & Trends Analysis Report By Scale of Operation (Preclinical / Clinical, Commercial), By Method Used, (Chemical Synthesis Method, Non-Chemical Synthesis Method), By Applications, By Synthesis Types, By Region, And By Segment Forecasts, 2025-2034

The Peptide CDMO (Pharmaceutical) Market Size is valued at 2.5 Bn in 2024 and is predicted to reach 6.6 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Peptides are bioactive molecules that bi...

View Sample PDF

SLIDE2~1.JPG

Viral and Non-Viral Vector Manufacturing Market Size, Share & Trends Analysis Report By Vector type (Viral Vector, Non-Viral Vector), By Disease (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases), By Application, By Region, And By Segment Forecasts, 2025-2034

Global Viral and Non-Viral Vector Manufacturing Market Size is valued at USD 8.0 Billion in 2024 and is predicted to reach USD 56.8 Billion by the year 2034 at a 21.9% CAGR during the forecast period for 2025-2034. Viral vectors are genetically mo...

View Sample PDF

sslld13.JPG

GLP-1 Agonists Market Size, Share & Trends Analysis Report by Product (Ozempic, Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda, Victoza, Zepbound, Other Products), by Application (Type 2 Diabetes Mellitus, Obesity), by Route of Administration (Parenteral, Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region And Segment Forecasts, 2025-2034

GLP-1 Agonists Market Size is valued at USD  43.1 billion in 2024 and is predicted to reach USD  260.1 billion by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034. GLP-1 agonists, known to be beneficial in treating...

View Sample PDF

Biologics_CDMO_Market.JPG

Biologics CDMO Market Size, Share & Trends Analysis Report By Cell Type (Mammalian, Non-mammalian), By Product Type (Biologics (Monoclonal Antibodies, Recombinant Proteins, Antisense and Molecular Therapy, Vaccines, Other Biologics, Biosimilars), By Region, And By Segment Forecasts, 2025-2034

Biologics CDMO Market Size is valued at USD  24.2 Bn in 2024 and is predicted to reach USD  125.5 Bn by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the report:  ...

View Sample PDF

Infographics_Next-Generation_Biomanufacturing.jpg

Next-Generation Biomanufacturing Market Size, Share & Trends Analysis Report By Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, Other Applications), By Products, By Workflow, By End-User, By Region, And By Segment Forecasts, 2025-2034

Next-Generation Biomanufacturing Market Size is valued at  24.9 Billion in 2024 and is predicted to reach  80.0 Billion by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from ...

View Sample PDF

slld8.JPG

Antisense Oligonucleotide Therapeutics Market Size, Share & Trends Analysis Report, Analysis Report By By ASO Generation (First-Generation, Second-Generation, Third-Generation, Next-Generation), By Phase of Development, By Route of Administration, By Type of Therapy, By Indications, and By Drug Type, By Region, Forecasts, 2025-2034

Global Antisense Oligonucleotide Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.1 Billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034. Antisense oligonucleotide is crucia...

View Sample PDF

sld10.JPG

U.S. and Europe Concierge Medicine Market Size, Share & Trends Analysis Report By Type (Independent Concierge Physician, Network-Affiliated Concierge Physician), By Specialty Areas, By Region, And Segment Forecasts, 2025-2034

Global U.S. and Europe Concierge Medicine Market Size is valued at USD 11.1 Billion in 2024 and is predicted to reach USD 33.0 Billion by the year 2034 at a 11.8% CAGR during the forecast period for 2025-2034. Concierge medicine is an emerging hea...

View Sample PDF

slld.JPG

Clinical Trials Software Market Size, Share & Trends Analysis Report, Type of Deployment (On-Cloud, On-Premises), Type of Delivery (Web-Based, Remote Monitoring), Type of End-User (Pharmaceuticals, Biotechnology, Cros), Features of Software (EDC, eCOA/ePRO, eConsent), Trial Design, Type of Technology. By Region, Forecasts, 2025-2034

Global Clinical Trials Software Market Size is valued at USD 0.9 Billion in 2024 and is predicted to reach USD 3.8 Billion by the year 2034 at a 15.8% CAGR during the forecast period for 2025-2034. Recently pharmaceutical companies started using c...

View Sample PDF

Categories